Summary of H.Res. 245 (Recognizing Sjögren’s Disease and Designating Sjögren’s Awareness Month)

Overview

H.Res. 245 is a House Resolution that recognizes Sjögren’s disease as a serious, systemic autoimmune disease and expresses support for designating April 2025 as “Sjögren’s Awareness Month.” The resolution is non-binding and serves to promote awareness and encourage federal action on research and information dissemination.

Purpose and Intent

• Acknowledge the health burden posed by Sjögren’s disease.
• Encourage federal agencies to prioritize research, understanding, and dissemination related to Sjögren’s disease.
• Designate a specific awareness month to highlight the condition and improve public and professional knowledge.

Key Provisions

1) Recognition
- The House recognizes Sjögren’s disease as a serious health issue that imposes a significant health burden.

2) Agency Outreach and Research Priorities (to be pursued by the Secretary of Health and Human Services and other relevant agency heads, through the Office of Autoimmune Disease Research)
- Expand, enhance, and increase Sjögren’s disease research.
- Identify new areas of research related to Sjögren’s disease.
- Improve understanding of the disease’s causes and identify biomarkers to aid in:
- patient stratification and diagnosis,
- disease management,
- development of targeted therapies.
- Better quantify and regularly track the number of Sjögren’s patients, addressing issues of underdiagnosis or misdiagnosis (including patients with Sjögren’s alongside other autoimmune diseases).
- Update and disseminate literature on Sjögren’s disease to health providers to improve awareness and knowledge.
- Build awareness among physicians and communities in underserved areas to ensure accurate diagnosis and access to care.

3) Awareness Designation
- Expresses support for designating April 2025 as “Sjögren’s Awareness Month.”

Legislative and Procedural Status

• Introduced: March 24, 2025
• Referred to: House Committee on Energy and Commerce
• Sponsorship: Representative Joseph D. Morelle (primary)

Affected Parties and Potential Impact

• Primary: Individuals with Sjögren’s disease and those affected by its management and diagnosis.
• Health professionals: Physicians, clinicians, and health systems receiving updated literature and awareness efforts.
• Researchers and funding bodies: Encouraged prioritization of Sjögren’s-specific research and biomarker development.
• Underserved communities: Targeted awareness and education to improve diagnosis and access to care.
• Note: As a non-binding resolution, it does not create new laws or mandatory funding; rather, it signals congressional support and may influence agency priorities within existing programs.

Next Steps

If advanced, the bill would move through additional House consideration and potentially to the Senate. Its impact rests largely in urging agency actions and awareness efforts rather than imposing new requirements or financial commitments.